http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-021055-B1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_30da9d43208368d956d262a97ab72a29 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2121-00 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4164 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4045 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4164 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 |
filingDate | 2010-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b907f5b5d00d3a5147f2b55ad30423ae |
publicationDate | 2015-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EA-021055-B1 |
titleOfInvention | METHOD FOR INCREASING THE SPEED OF TRIPTANES SUCTION AND METHOD FOR TREATING COMPLICATIONS OR MIGRAIN SYMPTOMS |
abstract | The present invention relates to a method for increasing the rate of absorption of sumatriptan, rizatriptan, naratriptan, zolmitriptan, eletriptan, almotriptan or frovatriptan, comprising administering to an individual having a migraine an effective amount of anamorelin or its pharmaceutically acceptable salt. The invention also relates to a method of treating migraine complications or symptoms, wherein said complications or symptoms are selected from gastric stasis, nausea, vomiting, photophobia and phonophobia, which includes the administration to an individual suffering from one or more of these complications or symptoms, an effective amount of anamorelin or its pharmaceutically acceptable salt and sumatriptan, rizatriptan, naratriptan, zolmitriptan, eletriptan, almotriptan or frovatriptan. The invention allows to increase the rate of absorption of triptans. |
priorityDate | 2009-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 312.